CHRNA4 and metabolic dysfunction-associated steatohepatitis: However, it highlights the need for dissecting subunit-specific biological roles of nAChRs in response to the local agonist, considering the complexity and heterogeneity of MASH pathogenesis in different conditions, by indicating hepatic CHRNA4 as an accelerator of MASH progression [70].